Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA.
J Neurosurg. 2010 May;112(5):913-9. doi: 10.3171/2009.6.JNS081490.
Although meningiomas are commonly found along the supratentorial convexity, the risk profile associated with this subset of lesions in the modern neurosurgical era is unknown.
The authors retrospectively reviewed the clinical course of patients with supratentorial convexity meningiomas treated during the past 10 years. All patients had undergone MR imaging within 72 hours after surgery and at least 1 year of clinical follow-up. Patients with multiple meningiomas, hemangiopericytomas, malignant meningiomas, or tumor-prone syndromes were excluded from analysis.
Between 1997 and 2007, 141 consecutive patients (median age 48 years, range 18-95 years) underwent resection of a supratentorial convexity meningioma. The most common signs or symptoms at presentation were headache (48%), seizures (34%), and weakness (21%). The mean tumor volume was 146.3 cm3 (range 1-512 cm3). There were no intraoperative complications or deaths. Medical or neurosurgical morbidity was noted in the postoperative course of 14 patients, equating to a 10% overall complication rate. Postoperative surgical complications included hematoma requiring evacuation, CSF leakage, and operative site infection. Medical complications included pulmonary embolus and deep vein thrombosis requiring treatment. A Simpson Grade 0 or 1 resection was achieved in 122 patients (87%). One hundred six tumors (75%) were WHO Grade I, whereas 35 (25%) were WHO Grade II. The median clinical follow-up was 2.9 years (range 1-10 years), and the median radiographic follow-up was 3.7 years (range 1-10 years). Six patients (4%) had radiographic evidence of tumor recurrence, with 3 (2%) undergoing repeat resection.
With the conservative recommendations for surgery for asymptomatic meningiomas and the advent of radiosurgery during the past 10 years, microsurgically treated convexity meningiomas are now typically large in size. Nevertheless, the patient's clinical course following microsurgical removal of these lesions is expected to be uncomplicated. The authors' findings provide a defined risk profile associated with the resection of supratentorial convexity meningiomas in the modern neurosurgical era.
尽管脑膜瘤常见于大脑凸面,但在现代神经外科时代,此类病变的风险特征尚不清楚。
作者回顾性分析了过去 10 年间手术治疗的大脑凸面脑膜瘤患者的临床病程。所有患者术后 72 小时内行 MRI 检查,且均获得至少 1 年的临床随访。多发性脑膜瘤、血管外皮细胞瘤、恶性脑膜瘤或肿瘤倾向综合征患者排除在分析之外。
1997 年至 2007 年间,141 例连续患者(中位年龄 48 岁,范围 18-95 岁)接受了大脑凸面脑膜瘤切除术。就诊时最常见的体征或症状是头痛(48%)、癫痫发作(34%)和无力(21%)。肿瘤平均体积为 146.3cm3(范围 1-512cm3)。无术中并发症或死亡。14 例患者术后出现内科或神经外科并发症,总并发症发生率为 10%。术后手术并发症包括需要清除的血肿、CSF 漏和手术部位感染。内科并发症包括需要治疗的肺栓塞和深静脉血栓形成。122 例患者(87%)实现了 Simpson Grade 0 或 1 级切除。106 个肿瘤(75%)为 WHO 1 级,35 个(25%)为 WHO 2 级。中位临床随访时间为 2.9 年(范围 1-10 年),中位影像学随访时间为 3.7 年(范围 1-10 年)。6 例患者(4%)有肿瘤复发的影像学证据,其中 3 例(2%)再次接受手术切除。
随着过去 10 年中对无症状脑膜瘤手术的保守建议和放射外科的出现,显微镜下治疗的凸面脑膜瘤现在通常体积较大。尽管如此,这些病变显微镜切除后的患者临床病程预计不会复杂。作者的研究结果为现代神经外科时代大脑凸面脑膜瘤切除术的风险特征提供了明确的定义。